Schedule 13G ownership disclosure

Cyclo Therapeutics, Inc.

Security class unavailable · CUSIP: 23254X102

Event date: 2020-08-27

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
16.0000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000919574-20-005625
Form type
SC 13G/A
Filer
ARMISTICE CAPITAL, LLC
CIK
CIK 1601086
Filed
Aug 31, 2020
Reporting period
Aug 27, 2020
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub